Table 1.

Patient Demographic Information and contemporary treatment status.

Patient Number	Age (Years)	Sex	MMSE	Length of Education (Years)	AD Treatment (in Disease Cohort, at Time of Biopsy)
1	63	Male	20	16	None
2	57	Male	18	15	Donepezil
3	53	Male	14	11	Donepezil
4 *	60	Male	18	9	None
5 *	59	Female	23	11	Galantamine
6 *	63	Female	26	10	Donepezil
7 *	60	Male	18	11	Memantine
8	60	Male	18	11	None
9	79	Female	28	15	None
10	61	Female	25	11	Donepezil
Group Mean (Standard Dev)	61.33 (7.19)		20.8 (4.4)	12.0 (2.4)
Controls
1	66	Male	29	11	NA
2 *	54	Male	27	17	NA
3 *	53	Male	29	16	NA
4 *	56	Male	24	11	NA
5	61	Female	30	NA	NA
6	54	Female	29	17	NA
7 *	100	Female	24 #	14	NA
8	75	Female	28	18	NA
9	73	Female	26	12	NA
10	75	Male	27	10	NA
Group Mean (Standard Dev)	65.77 (14.7)		27.6 (1.8)	14 (3.1)

# For control 7 some items of the Mini Mental State Examination (MMSE) could not be tested due to sensory impairment * indicates fibroblast lines in which Mitochondrial Membrane Potential (MMP) and Mitochondrial Spare Respiratory Capacity (MRSC) values were published in our previous paper [29].